125 related articles for article (PubMed ID: 8095024)
1. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
Chan SL; Brown CA; Morgan NG
Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
3. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
4. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
Chan SL; Dunne MJ; Stillings MR; Morgan NG
Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
[TBL] [Abstract][Full Text] [Related]
5. The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans.
Tsoli E; Chan SL; Morgan NG
Eur J Pharmacol; 1995 Sep; 284(1-2):199-203. PubMed ID: 8549627
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
7. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
Mourtada M; Smith SA; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.
Brown CA; Loweth AC; Smith SA; Morgan NG
Br J Pharmacol; 1993 Feb; 108(2):312-7. PubMed ID: 8095415
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
Chan SL; Mourtada M; Morgan NG
Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
[TBL] [Abstract][Full Text] [Related]
10. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat.
Berdeu D; Gross R; Puech R; Loubatières-Mariani MM; Bertrand G
Eur J Pharmacol; 1995 Feb; 275(1):91-8. PubMed ID: 7774667
[TBL] [Abstract][Full Text] [Related]
11. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets.
Chan SL; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):267-72. PubMed ID: 9696417
[TBL] [Abstract][Full Text] [Related]
12. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of efaroxan and beta-carbolines on the secretory activity of rodent and human beta cells.
Morgan NG; Cooper EJ; Squires PE; Hills CE; Parker CA; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():167-74. PubMed ID: 15028583
[TBL] [Abstract][Full Text] [Related]
14. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.
Chan SL; Brown CA; Scarpello KE; Morgan NG
Br J Pharmacol; 1994 Aug; 112(4):1065-70. PubMed ID: 7952865
[TBL] [Abstract][Full Text] [Related]
15. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in stimulation of insulin secretion by the hypoglycaemic alpha-adrenergic antagonist, DG-5128.
Chan SL; Stillings MR; Morgan NG
Biochem Biophys Res Commun; 1991 May; 176(3):1545-51. PubMed ID: 1674868
[TBL] [Abstract][Full Text] [Related]
17. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
Chan SL; Atlas D; James RF; Morgan NG
Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
[TBL] [Abstract][Full Text] [Related]
18. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.
Mourtada M; Chan SL; Smith SA; Morgan NG
Br J Pharmacol; 1999 Jul; 127(5):1279-87. PubMed ID: 10455276
[TBL] [Abstract][Full Text] [Related]
19. Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed.
Berdeu D; Puech R; Loubatières-Mariani MM; Bertrand G
Eur J Pharmacol; 1996 Jul; 308(3):301-4. PubMed ID: 8858303
[TBL] [Abstract][Full Text] [Related]
20. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
